Bodyport to present real-world heart failure outcomes at THT 2026
Dr. Marat Fudim will present findings from Bodyport’s Cardiac Scale and Congestion Index on March 4, 2026.
Read announcement ↗Partnerships, company announcements, and coverage of our work advancing at-home cardiovascular monitoring.
Sutter Health has expanded its Sutter Sync™ remote monitoring program to patients with heart failure using the FDA-cleared Bodyport Cardiac Scale.
Read announcement ↗.png)
Dr. Marat Fudim will present findings from Bodyport’s Cardiac Scale and Congestion Index on March 4, 2026.
Read announcement ↗Bodyport announces results from the multicenter SCALE-HF 1 study.
Read update ↗MedCity News reports on Geisinger’s planned 200-patient pilot using Bodyport’s Cardiac Scale for at-home heart failure monitoring.
Read article ↗Bodyport announces FDA 510(k) clearance for its noninvasive Cardiac Scale.
Read update ↗Discussion of the Bodyport platform, monitoring technology, and patient experience.
Read interview ↗Coverage of the 4YouAndMe study and longitudinal maternal-health monitoring.
Read article ↗MedCity News covers Bodyport’s $11.2 million Series A financing and research collaboration with Brigham and Women’s Hospital.
Read article ↗Initialized Capital’s Garry Tan explains why the firm backed Bodyport and discusses the company’s connected scale and at-home monitoring approach.
Read article ↗See the clinical studies and publications behind the technology.